BiotechTube
Home/DeuterOncology/Prof Jaap Verweij
PJ

Prof Jaap Verweij

Chief Medical Officer

DeuterOncology

Therapeutic Areas

OncologyLung Cancer

DeuterOncology Pipeline

DrugIndicationPhase
DO-2MET-altered NSCLC & Advanced Solid TumorsPhase 1
DO-1Not specifiedPre-clinical

Leadership Team at DeuterOncology

DT
Dr Timothy Perera
Founder & Chief Executive Officer
EH
Els Hubloux Chier
Financial Officer
View full DeuterOncology profile